Vendor, selecting

The lack of homogeneity and the friable nature of FRP composite structures dictate that caution be followed in mechanical design, vendor selection, inspection, shipment, installation, and use. 

Vendor selection and development, for the inputs that go into the production of the items... 

Laboratory automation in pharmaceutical analysis attained maturity since robots first appeared in pharmaceutical laboratories more than 20 years ago. While automation offers great promise for improving sample throughput and reducing sample backlog, its implementation has not been without problems. The industry cannot invest heavily in tools that produce little return on investment. Strategies in key aspects of automation such as planning, vendor selection, personnel, and efficient use of systems can determine the success or failure of an automation project. 

Qualification of equipment and validation of computer systems are not one-time events. They start with the definition of the product or project and setting user requirement specifications and cover the vendor selection process, installation, initial operation, ongoing use, and change control. 

Testing procedures were established for each vendor selected for on-site demonstration of filtration equipment. These procedures were based on the need for testing data to properly complete the final equipment specifications and purchase justification. 

Large accounts that may encompass entire manufacturing sites or multisite, nationwide businesses are particularly difficult to win. And, even if there are valid reasons to change, the process may take many months, or even years. A further problem is that often the ultimate decision on vendor selection takes place behind closed doors, without the vendor actually being present. Thus sellers have to rely on their primary buyers to conduct the sale on the seller s behalf (third-party selling). If the proposal is not clear and concise, with appropriate cost and benefit summaries, or if the primary buyer has not been properly sold to and does not fully comprehend the key details of the proposal, it is unlikely that the sale will proceed. 

As argued in Chapter 2.1.2 this work focuses on production network design. Demand is assumed to be independent of production network design decisions and the cost structure achieved. Also, unlimited quantities of raw materials are assumed to be available. An extensions to include make-or-buy decisions (and possibly vendor selection) is provided to accommodate application cases where sourcing decisions have to be included. 

While raw material supply is usually taken for granted, some models also include vendor selection, vendor capacity constraints or vendor delivery reliability (e.g., Martel et al. 2005 Vidal and Goetschalckx 2000 Vidal and Goetschalckx 1996). 

The basic model presented in Chapter 3.4.2 distinguishes between internally manufactured intermediates and externally procured raw materials without considering make or buy options for intermediates. For some application cases it might however be required to include make or buy - decisions in the network design model. The decision can be made either for the entire production network or individually for each site. In order to incorporate make or buy - decisions (and possibly vendor selection), suppliers have to be modeled as an additional network node. Table 11 contains the additional indices, parameters and decision variables required to implement a make or buy formulation for intermediates. 

Extensions to incorporate effects of taxation, an explicit modeling of product-mix effects (economies of scale and scope), make or buy/vendor selection and additional elements of technical capacity such as shared resources are provided in Chapter 3.4.3 to allow for an application to value chains with characteristics that differ from those that were considered when developing the model. 

The first section is site qualification. Vendors selected to perform regulated work product will be evaluated for compliance with the appropriate s et of regulations. The results of the audit will be reviewed and the need for a site follow-up visit will be determined. Site qualification visits are generally performed on a cyclical basis at least once every 24 months is suggested unless the supplier becomes problematic. A continuous monitoring program is an essential component of a compliant vendor qualification program. 

Excipient and vendor selections can greatly influence the new drag development timeline, product performance, and acceptance of final products. Compendial excipients have composition consistent with monographs published in compendia such as USP-NF these are the better-characterized excipients. These excipients most likely possess desirable qualities and are preferred excipients for pharmaceutical formulations. Non-compendial excipients can also be used for drug products if they are supported by Type IV dmg master files (DMFs) in regulatory dossiers. Overall, a good excipient supplier should 29... 

Diratsaoglu, J. 2007. Compound management workflow and best practices in vendor selection and collaboration. Am. Drug Disc. 3, 18-19. 

Reqnirements Captnre and Snpplier (Vendor) Selection Design and Development Coding, Confignration and Bnild Development Testing... 

Develop criteria for vendor selection, and check if criteria are met. 

---